Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Leukemia, Acute Myelogenous (AML)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01135329
What this trial is testing

Reduced-intensity, Related-donor Bone Marrow Transplantation Followed by High-dose Cyclophosphamide for Hematologic Cancers

Who this might be right for
LymphomaLeukemiaMyelodysplastic Syndrome
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 15
Post-approval studies (Phase 4)UnknownNCT03026842
What this trial is testing

Decitabine Versus Conventional Chemotherapy for Maintenance Therapy of Acute Myeloid Leukemia With t(8;21)

Who this might be right for
Acute Myeloid Leukemia
The First Hospital of Jilin University 180
Not applicableStudy completedNCT03435341
What this trial is testing

Survival in Patients Older Than 60 Years With Newly Diagnosed AML in Spain

Who this might be right for
Leukemia, Myeloid, Acute
Celgene 151
Testing effectiveness (Phase 2)Ended earlyNCT01794169
What this trial is testing

Azacitidine Compared to Conventional Chemotherapy as Consolidation of Elderly Patients With AML

Who this might be right for
Acute Myeloid Leukemia
Karolinska University Hospital 130
Early research (Phase 1)Study completedNCT00466895
What this trial is testing

Lenalidomide in Acute Leukemias and Chronic Lymphocytic Leukemia.

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaChronic Lymphocytic Leukemia
Leslie Andritsos 37
Testing effectiveness (Phase 2)Ended earlyNCT00450983
What this trial is testing

Donor Peripheral Stem Cell Transplant and Donor Natural Killer Cell Transplant After Total-Body Irradiation, Thiotepa, Fludarabine, and Muromonab-CD3 in Treating Patients With Leukemia or Other Blood Diseases

Who this might be right for
Graft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes
Fred Hutchinson Cancer Center 1
Not applicableAvailableNCT03123029
What this trial is testing

Expanded Access to Venetoclax

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)Multiple MyelomaAcute Myeloid Leukemia (AML)+4 more
AbbVie
Testing effectiveness (Phase 2)Study completedNCT01664897
What this trial is testing

Erlotinib Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeAdult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11+8 more
M.D. Anderson Cancer Center 29
Early research (Phase 1)WithdrawnNCT02487459
What this trial is testing

Safety Study of Gene Modified Donor T-Cells in Adults With Advanced Hematologic Malignancies

Who this might be right for
Hematologic Malignancies
Bellicum Pharmaceuticals
Not applicableUnknownNCT05017883
What this trial is testing

TAA05 Cell Injection in the Treatment of Recurrent / Refractory Acute Myeloid Leukemia

Who this might be right for
CARAcute Myeloid Leukemia
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 5
Early research (Phase 1)Active Not RecruitingNCT05455294
What this trial is testing

Combination Navitoclax, Venetoclax and Decitabine for Advanced Myeloid Neoplasms

Who this might be right for
Myeloid MalignancyMyelodysplastic SyndromesMyelofibrosis+2 more
Jacqueline Garcia, MD 16
Testing effectiveness (Phase 2)UnknownNCT04964518
What this trial is testing

APG-2575 in Combination With Azacitidine in Patients With Acute Myeloid Leukemia (AML)

Who this might be right for
AML, Adult
Ascentage Pharma Group Inc. 24
Testing effectiveness (Phase 2)Ended earlyNCT00961142
What this trial is testing

Haploidentical Stem Cell Transplantation With CD3/CD19 Depletion and Reduced Intensity Conditioning in Patients With Acute Leukemia

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic Leukemia
University Hospital Tuebingen 23
Not applicableActive Not RecruitingNCT04482894
What this trial is testing

Palliative Care Oncology in Patients With Relapsed, Refractory, and High-Risk Leukemias or MDS

Who this might be right for
Leukemia, AcuteAML, AdultALL, Adult+1 more
University of Virginia 105
Testing effectiveness (Phase 2)Looking for participantsNCT06793410
What this trial is testing

Vaccination Against Human Papillomavirus (HPV) After Allogeneic Stem Cell Transplantation

Who this might be right for
Recipients of Allogeneic Stem Cell TransplantationHPV (Human Papillomavirus)-AssociatedAcute Myeloid Leukaemia+2 more
Vastra Gotaland Region 100
Not applicableActive Not RecruitingNCT07458542
What this trial is testing

Effectiveness and Safety of ONUREG (Oral Azacitidine) in Chinese Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia (AML)
Bristol-Myers Squibb 44
Not applicableLooking for participantsNCT06256627
What this trial is testing

The Maintenance Treatment of "ITIVA" in AML Patients

Who this might be right for
Acute Myeloid LeukemiaMaintenance TreatmentMinor Residue Disease+5 more
Henan Cancer Hospital 130
Testing effectiveness (Phase 2)Ended earlyNCT00268242
What this trial is testing

Gemcitabine and Mitoxantrone in Treating Patients With Relapsed Acute Myeloid Leukemia

Who this might be right for
Leukemia
The Cleveland Clinic 24
Large-scale testing (Phase 3)Active Not RecruitingNCT03897127
What this trial is testing

Study of Standard Intensive Chemotherapy Versus Intensive Chemotherapy With CPX-351 in Adult Patients With Newly Diagnosed AML and Intermediate- or Adverse Genetics

Who this might be right for
Acute Myeloid Leukemia
University of Ulm 882
Very early researchWithdrawnNCT07123662
What this trial is testing

Γδ T Cell Therapy for Relapse Prevention in High-Risk AML Post-Transplant

Who this might be right for
LeukemiaMyeloidAcute
Guangzhou Bio-gene Technology Co., Ltd
Next Page